All News

The U.S. Patent and Trademark Office issued patent numbers to cover Aureon Laboratories, Inc.?s systems and methods for evaluating the occurrence of any medical condition in a patient where clinical, imaging, and molecular data are combined and appraised.

Two drugs aimed at stemming bone loss in men with prostate cancer have moved closer to FDA approval.

Low-income men are more likely to present with advanced prostate cancers, most likely because they do not receive screening services shown to reduce the diagnosis of later-stage cancers, according to a study by UCLA researchers.

Ferring Pharmaceuticals, USA has received FDA approval to market degarelix, an injectable gonadotropin-releasing hormone (GnRH) receptor antagonist, indicated for patients with advanced prostate cancer.

Universal intraoperative cystoscopy following hysterectomy allows immediate repair of injuries to the ureter and bladder that would otherwise go undetected, according to a study published in Obstetrics & Gynecology (2009; 113:6-10).

Inderbir S. Gill, MD, has been appointed chair of the University of Southern California, Los Angeles Catherine and Joseph Aresty Department of Urology, effective Feb. 1.

In a new study that appears to refute earlier research, Massachusetts General Hospital researchers have found that treating prostate cancer patients with gonadotropin-releasing hormone (GnRH) agonists does not appear to increase the risk of death from cardiovascular disease.

Your interactive guide to ambulatory and surgical urology, practice management, and other physician topics available at modernmedicine.com.

What is an improper payment?

In this interview, Margaret S. Pearle, MD, PhD, discusses the diagnosis, treatment, surgical skills, and training needed to manage challenging kidney stones.

The outline of health care reform under the Obama presidency is beginning to take shape. While there will be positive developments for urologists, there are also areas of potential concern.

Federal regulators have judged the first phase of the Medicare Recovery Audit Contractor (RAC) program a success, but the controversial plan promises potential headaches for physicians as it moves into its second phase.

New Products & Services

Contemporary financial challenges call for creative thinking on the part of the physician-cum-small business operator. One idea that is gaining popularity is in-office dispensing of medications.

Like everyone else, I'm frustrated and confused by the stock market and the global economic situation. How can I reduce the risk in my portfolio but still have it grow for the long term?

Physicians and managers are accustomed to dealing with staff members who aren't happy at work and can't seem to get along, but what do you do when it's the physicians and management who are at odds?

There is no code for a radical cystectomy. You will have to use the code for a "total" cystectomy.

Vesicoureteral reflux (VUR) is a common congenital anomaly affecting close to 1% of all children. It is often associated with other ureteral anomalies, including ureteral duplication, ectopia, ureteroceles, and paraureteral (Hutch) diverticula.

Two studies of blunt kidney trauma, one from Switzerland and one from the United States, reached essentially the same conclusion: Conservative management is likely to be the best path when confronting most cases of blunt renal trauma.

Based on new mid-term study results, robot-assisted laparoscopic cystectomy appears to be slowly moving toward mainstream surgical practice.

Vesicoureteral reflux appears to be the most common complication of ureteral reimplantation at the time of kidney transplantation, as indicated by findings from St. Barnabas Healthcare System, Livingston, NJ.

Statin drugs appear to have no effect on intravesical bacillus Calmette-Guerin (BCG) treatment outcomes in patients with non-muscle invasive bladder cancer, according to a recent retrospective study among Veterans Affairs patients in St. Louis.

Perirenal hematoma characteristics determined by computed tomography may be suggestive of the need for angiographic embolization in patients who present with blunt renal trauma, a study from the University of Texas Southwestern Medical Center, Dallas, suggests.

"I am optimistic about urology, regardless of what the president does."

The practicing urologist faces an increasingly common dilemma: How should I treat this incidentally discovered small renal mass?

Urology Times asked urologists around the country whether the ability of a dissatisfied patient to broadcast his discontent on the Internet has changed the way they deal with those patients and whether additional measures are needed to prevent those patients from trashing a physician's reputation online.

Second-look flexible nephroscopy after percutaneous nephrolithotomy is cost-effective only for patients who have larger residual stone fragments.

Rising temperatures associated with global warming may be accompanied by a significant, costly increase in the incidence of kidney stones. Climate change may increase stone incidence rates by up to 30% in some regions.